AptarGroup, Inc.
NYQ: ATRLive Quote
📈 ZcoreAI Score
Our AI model analyzes AptarGroup, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get ATR Z-Score →About AptarGroup, Inc.
Healthcare
Medical Instruments & Supplies
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
📊 Fundamental Analysis
AptarGroup, Inc. demonstrates a profit margin of 10.4%, which is below the sector average, suggesting competitive pressure.
The company recently reported 13.5% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 15.1%, which suggests room for improvement in capital utilization.
At a current price of $131.50, ATR currently sits at the 46th percentile of its 52-week range (Range: $103.23 - $164.28).
💰 Valuation Insight
ATR is valued broadly in line with the sector at a PE of 22.33. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
⚠️
Debt/Equity
Moderate
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$8.47B
Trailing P/E
22.33
Forward P/E
20.66
Beta (5Y)
0.49
52W High
$164.28
52W Low
$103.23
Avg Volume
530K
Day High
Day Low